{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:21:56Z","timestamp":1779110516469,"version":"3.51.4"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,5,4]],"date-time":"2012-05-04T00:00:00Z","timestamp":1336089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00520-012-1474-z","type":"journal-article","created":{"date-parts":[[2012,5,3]],"date-time":"2012-05-03T02:27:28Z","timestamp":1336012048000},"page":"2195-2197","source":"Crossref","is-referenced-by-count":34,"title":["Advanced prostate cancer as a cause of oncogenic osteomalacia: an underdiagnosed condition"],"prefix":"10.1007","volume":"20","author":[{"given":"Milena Perez","family":"Mak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f4nica Torres","family":"da Costa e Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina Matsunaga","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio Marcondes","family":"Lerario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Marcelo Gehm","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gilberto","family":"de Castro Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,5,4]]},"reference":[{"key":"1474_CR1","doi-asserted-by":"crossref","first-page":"6243s","DOI":"10.1158\/1078-0432.CCR-06-0931","volume":"12","author":"RE Coleman","year":"2006","unstructured":"Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12:6243s\u20136249s","journal-title":"Clin Cancer Res"},{"key":"1474_CR2","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1530\/ERC-11-0006","volume":"18","author":"WH Chong","year":"2011","unstructured":"Chong WH, Molinolo AA, Chen CC, Collins MT (2011) Tumor-induced osteomalacia. Endocr Relat Canc 18:R53\u2013R77","journal-title":"Endocr Relat Canc"},{"key":"1474_CR3","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1053\/j.ajkd.2007.07.031","volume":"50","author":"CL Cotant","year":"2007","unstructured":"Cotant CL, Rao PS (2007) Elevated fibroblast growth factor 23 in a patient with metastatic prostate cancer and hypophosphatemia. Am J Kidney Dis 50:1033\u20131036","journal-title":"Am J Kidney Dis"},{"key":"1474_CR4","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, J\u00fcppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656\u20131663","journal-title":"N Engl J Med"},{"key":"1474_CR5","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1210\/jc.80.5.1628","volume":"80","author":"GE Wilkins","year":"1995","unstructured":"Wilkins GE, Granleese S, Hegele RG, Holden J, Anderson DW, Bondy GP (1995) Oncogenic osteomalacia: evidence for a humoral phosphaturic factor. J Clin Endocrinol Metab 80:1628\u20131634","journal-title":"J Clin Endocrinol Metab"},{"key":"1474_CR6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2004.09.017","volume":"36","author":"RC Pelger","year":"2005","unstructured":"Pelger RC, Lycklama ANGA, Papapoulos SE, Hamdy NA (2005) Severe hypophosphatemic osteomalacia in hormone-refractory prostate cancer metastatic to the skeleton: natural history and pitfalls in management. Bone 36:1\u20135","journal-title":"Bone"},{"key":"1474_CR7","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1200\/JCO.2005.05.043","volume":"23","author":"P Auethavekiat","year":"2005","unstructured":"Auethavekiat P, Roberts JR, Biega TJ, Toney MO, Christensen RS, Belnap CM, Berenberg JL (2005) Case 3. Oncogenic osteomalacia associated with hemangiopericytoma localized by octreotide scan. J Clin Oncol 23:3626\u20133628","journal-title":"J Clin Oncol"},{"key":"1474_CR8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1259\/0007-1285-48-570-451","volume":"48","author":"DJ Hosking","year":"1975","unstructured":"Hosking DJ, Chamberlain MJ, Shortland-Webb WR (1975) Osteomalacia and carcinoma of prostate with major redistribution of skeletal calcium. Br J Radiol 48:451\u2013456","journal-title":"Br J Radiol"},{"key":"1474_CR9","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","volume":"377","author":"K Fizazi","year":"2011","unstructured":"Fizazi K, Carducci M, Smith M, Dami\u00e3o R, Brown J, Karsh L, Milecki P, Shore N, Rader M, Wang H, Jiang Q, Tadros S, Dansey R, Goessl C (2011) Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet 377:813\u2013822","journal-title":"Lancet"},{"key":"1474_CR10","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1093\/jnci\/djh141","volume":"96","author":"F Saad","year":"2004","unstructured":"Saad F, Gleason DM, Murray R, Tchekmedyian S, Venner P, Lacombe L, Chin JL, Vinholes JJ, Goas JA, Zheng M, Zoledronic Acid Prostate Cancer Study Group (2004) Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Canc Inst 96:879\u2013882","journal-title":"J Natl Canc Inst"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1474-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-012-1474-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-012-1474-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T02:04:17Z","timestamp":1559095457000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-012-1474-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,4]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["1474"],"URL":"https:\/\/doi.org\/10.1007\/s00520-012-1474-z","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5,4]]}}}